Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    Licensing         0.9
    Products         143.5
    Royalty revenue         3.0
Total revenues   [+]667.2579.8520.4392.8408.9302.2215.0147.5
            Revenue growth   [+]15.1%11.4%32.5%-3.9%35.3%40.6%45.8%59.1%
Cost of goods sold  86.768.554.416.715.415.212.08.4
Gross profit  580.5511.2466.0376.1393.5287.0203.0139.0
            Gross margin  87.0%88.2%89.6%95.8%96.2%95.0%94.4%94.3%
Selling, general and administrative  377.2304.8200.7153.2154.7137.9106.089.1
Research and development  74.690.576.069.189.249.642.829.1
Other operating expenses  1.06.5-1.9     
EBITDA   [+]130.6112.1193.7155.2151.5107.756.621.8
            EBITDA margin  19.6%19.3%37.2%39.5%37.1%35.6%26.3%14.8%
Depreciation  2.92.62.41.51.91.21.10.7
EBITA  127.7109.5191.3153.8149.6106.455.521.0
            EBITA margin  19.1%18.9%36.8%39.1%36.6%35.2%25.8%14.3%
Amortization of intangibles  82.630.015.75.25.26.91.30.2
EBIT   [+]45.179.5175.6148.6144.499.554.220.8
            EBIT margin  6.8%13.7%33.7%37.8%35.3%32.9%25.2%14.1%
Non-recurring items   [+]-1.0-6.51.9     
Interest expense, net   [+]    -13.8-2.9-0.90.5
Other income (expense), net   [+]19.36.814.417.1-4.3-1.7-4.8-5.7
Pre-tax income  60.773.2168.6147.5140.2100.650.414.6
Income taxes  0.019.841.734.429.243.3-40.90.7
            Tax rate  0.1%27.0%24.7%23.3%20.8%43.1% 4.6%
Net income  60.753.4127.0113.1111.057.391.213.9
            Net margin  9.1%9.2%24.4%28.8%27.1%19.0%42.4%9.5%
   
Basic EPS   [+]$1.13$1.01$2.41$2.16$2.13$1.13$1.84$0.29
Diluted EPS   [+]$0.98$0.98$2.36$2.10$2.05$1.07$1.76$0.27
   
Shares outstanding (basic)   [+]53.753.152.652.452.050.849.547.5
Shares outstanding (diluted)   [+]61.754.453.753.854.153.351.751.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy